RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.12% | 23.84% | -73.56% | 6.76% | 16.71% |
| Total Depreciation and Amortization | -7.01% | 19.78% | -2.00% | -0.35% | 10.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.86% | 14.37% | -6.82% | 9.47% | -21.15% |
| Change in Net Operating Assets | 1,065.37% | -174.85% | -441.10% | -66.53% | 272.26% |
| Cash from Operations | 574.06% | 12.42% | -875.90% | 5.98% | 72.87% |
| Capital Expenditure | 39.98% | -157.71% | 33.25% | -95.70% | 62.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.01% | -31.22% | 213.33% | -0.64% | -152.03% |
| Cash from Investing | 70.81% | -47.42% | 192.03% | -6.77% | -161.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -177.78% | 147.37% | -533.33% |
| Issuance of Common Stock | -66.07% | 364.58% | -86.36% | 706.11% | -93.67% |
| Repurchase of Common Stock | -- | 100.00% | -23,550.00% | 99.69% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -70.54% | 297.02% | -131.61% | 300.57% | -125.67% |
| Foreign Exchange rate Adjustments | 166.67% | 0.00% | 120.00% | -650.00% | -114.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,364.27% | -77.65% | 75.46% | 9.70% | -186.79% |